14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
It is becoming increasingly clear that the impact of the pandemic will continue to be felt once lock...
Read More >
California employers are not alone as they wrestle with AB 51’s January 1, 2020 new law on mandator...
Read More >
Believe it or not, the Supreme Court of the United States just decided whether “to have ‘actual kn...
Read More >
Since October 24, 2019, blind and vision-impaired individuals have filed more than ninety lawsuits c...
Read More >
Just yesterday, the Pennsylvania Supreme Court issued a decision in a case involving the “fluctuati...
Read More >
On September 24, 2019, the US Department of Labor announced a finalized rule increasing the earnings...
Read More >